Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Biliary Tract Cancer”
Approved 1
- DurvalumabASTRAZENECA PLCBiliary Tract Cancer
Phase 3 1
- RilvegostomigASTRAZENECA PLCBiliary Tract Cancer
Phase 2/3 1
- CTX-009Compass Therapeutics, Inc.Biliary Tract Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.